As of January 22, 2025, Astellas Pharma (4503.T) has a market cap of $17.10 billion USD. According to our data, Astellas Pharma is ranked No.1080 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $17.10 B |
-3.16%
|
Dec 30, 2024 | $17.66 B |
-5.02%
|
Dec 29, 2023 | $18.59 B |
-13.23%
|
Dec 30, 2022 | $21.42 B |
10.42%
|
Dec 30, 2021 | $19.40 B |
20.38%
|
Dec 30, 2020 | $16.12 B |
-12.64%
|
Dec 30, 2019 | $18.45 B |
36.69%
|
Dec 31, 2018 | $13.50 B |
-0.39%
|
Dec 29, 2017 | $13.55 B |
-9.35%
|
Dec 30, 2016 | $14.95 B |
-4.27%
|
Dec 30, 2015 | $15.62 B |
4.53%
|
Dec 30, 2014 | $14.94 B |
38.17%
|
Dec 30, 2013 | $10.81 B |
64.98%
|
Dec 28, 2012 | $6.55 B |
28.22%
|
Dec 30, 2011 | $5.11 B |
5.48%
|
Dec 30, 2010 | $4.85 B |
-7.03%
|
Dec 30, 2009 | $5.21 B |
-1.33%
|
Dec 30, 2008 | $5.28 B |
-23.29%
|
Dec 28, 2007 | $6.89 B |
-8.42%
|
Dec 29, 2006 | $7.52 B |
19.66%
|
Dec 30, 2005 | $6.28 B |
16.63%
|
Dec 31, 2004 | $5.39 B |
20.86%
|
Dec 31, 2003 | $4.46 B |
-2.60%
|
Dec 31, 2002 | $4.58 B |
-0.32%
|
Dec 31, 2001 | $4.59 B |
-29.49%
|
Dec 29, 2000 | $6.51 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Gilead Sciences
GILD
|
$116.07 B |
0.004 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
Takeda Pharmaceutical
TAK
|
$41.01 B |
-0.002 M
|
Japan
|
Biogen
BIIB
|
$20.80 B |
-0.001 M
|
USA
|
Market Cap | = | 4503.T Stock Price | * | 4503.T Shares Outstanding |
= | $9.55 | * | 1.79 B | |
= | $17.10 B |